Bruce Neal is Professor of Medicine at UNSW Sydney and Executive Director of The George Institute Australia. Bruce has broad-based clinical and public health research expertise with a strong focus on the translation of research findings into enhanced clinical care and better government policies. He has particular experience in the fields of high blood pressure and diabetes and has played lead roles in multiple large-scale clinical trials. Most recently he has led large studies of the novel blood pressure lowering drug class SGLT2 inhibitors and salt substitute.